News/ News/ Sales and Marketing AZ pays $775m to settle patent dispute with Chugai over Ultomiris Phil Taylor Alexion, AstraZeneca, Chugai, patent litigation, Roche, Ultomiris 0 Comment AstraZeneca has resolved a lingering liability following its takeover of Alexion with an agreement to pay $775 million Share X AZ pays $775m to settle patent dispute with Chugai over Ultomiris https://pharmaphorum.com/news/az-pays-775m-to-settle-patent-dispute-with-chugai-over-ultomiris/
R&D/ Views & Analysis/ Views and analysis Why starting an innovation journey isn’t sexy mike.hammerton@pharmaphorum.com Chugai, Innovation 0 Comment Chugai Pharmaceutical’s UK innovation lead, Martin Ellgood explores the challenges pharma companies face when devising innovation strategies. On Share X Why starting an innovation journey isn’t sexy https://pharmaphorum.com/r-d/views-analysis-r-d/why-starting-an-innovation-journey-isnt-sexy/
Market Access/ News/ News Scotland’s NHS to fund Roche’s Hemlibra in haemophilia A Richard Staines Chugai, haemophilia A, market access, Roche 0 Comment NHS patients in Scotland with haemophilia A are set to get access to Roche and Chugai’s prophylactic injection Share X Scotland’s NHS to fund Roche’s Hemlibra in haemophilia A https://pharmaphorum.com/news/scotlands-nhs-to-fund-roches-hemlibra-in-haemophilia-a/
Alexion, AstraZeneca, Chugai, patent litigation, Roche, Ultomiris
0 Comment
